Now showing items 1-2 of 2
Pharmaceutical assistance programs to support smoking cessation medication access
OBJECTIVES: Rural smokers are more likely to be uninsured and live in poverty, which may pose significant cost barriers to accessing smoking cessation medications. As part of a randomized clinical trial, we provided support ...
Patient Organizations’ Barriers in Pharmacovigilance and Strategies to Stimulate Their Participation
European drug regulations aim for a patient-centered approach, including involving patients in the pharmacovigilance (PV) systems. However many patient organizations have little experience on how they can participate in ...